Cortical Bone Assessment Using Ultrasonic Guided Waves: Towards a Robust Clinical Measurement
NCT ID: NCT05424536
Last Updated: 2026-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2022-07-18
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Even if DXA remains the current gold standard, it is limited by the difficulty to set a threshold in the BMD distribution for osteoporosis diagnosis. Moreover, some medical conditions (chronic kidney disease, diabetes) or drugs (glucocorticoids) are associated with an increase of fracture risk without a BMD decrease. Quantitative ultrasound (QUS) have the advantages of portability, low cost, absence of radiation and need for a radiographic technologist or designated room, and are sensitive to both elasticity and geometry of the medium explored by the waves. Among QUS techniques, axial transmission (AT) is a technique for which transducers are aligned along the bone axis. Measured ultrasonic guided waves, associated with an appropriate waveguide model have the potential to yield estimates of material and/or geometrical cortical properties. In vivo combined estimation of both cortical thickness and porosity has been proposed using bidirectional axial transmission (BDAT). BDAT measurement has been recently validated on ex vivo specimen (radius and tibia) and has been tested in a pilot clinical study, in which cortical porosity measured at the one-third distal radius has been found as discriminant of low trauma fractures as DXA. Cortical porosity is increasingly recognized as a major contributor to bone fragility.
The hypothesis underlying this project are that (1) it is possible to obtain robust and accurate estimates of cortical thickness and porosity using an improved BDAT device and (2) these estimates are of clinical interest in the context of osteoporosis in elderly. Moreover, novel parameters obtained from automatic classification tools will be tested.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Develop and Validate Ultrasonic Device for Osteoporotic Fracture Risk Assessment
NCT01123421
Advancing Early Bone Health: New Frontiers for Osteoporosis Prevention
NCT06750523
Ultrasound Imaging-based Measurement of Intra-osseous Vascular Response
NCT04396288
Age Influence on Cortical Bone Measured by Ultrasound
NCT03453242
The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures
NCT07027306
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Results will be compared to the current gold standard dual-energy X-ray absorptiometry (DXA) of the hip, spine and forearm, obtained from all subjects. The BDAT device with the improved interface will be tested in a clinical environment by clinical operators on:
* minimum sample size per group: 25 for cases and controls (female and male, over 50 years).
* Fractured patients will be obtained at the traumatology service of Fricke Hospital (Viña del Mar) which receives about 350 patients with hip fractures per year.
* Control will be obtained at the community health centers of Valparaiso in collaboration with the UV project Geropolis.
DXA measurement will be done at the imaging center of the Universidad Catolica de Valparaiso (PUCV, FONDEQUIP EQM160142). Additional DXA parameters concerning muscle and fat, will be taken into account.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bone measurement by DXA and ultrasound
Measurement will be performed at radius and at tibia (ultra-distal and distal). For all the sites plus femoral neck, one measurement will be performed by DXA to get reference values of thickness and BMDs. For the distal positions and additional measurement will be performed by an innovative ultrasound device that estimates cortical thickness and porosity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Recent femoral bone fragility fracture
Exclusion Criteria
* Corticoid treatment
* Renal disease
* Arthritis
* BMI \< 15 and \> 30
* Double femoral prosthesis
In case group/with fracture is added:
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Valparaiso
OTHER
Pontificia Universidad Catolica de Valparaiso
OTHER
Centro Gerópolis UV, Valparaíso
UNKNOWN
Centro de Salud Familiar Marcelo Mena
UNKNOWN
Hospital Dr. Gustavo Fricke, Valparaíso
UNKNOWN
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Gabriel Minonzio, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Universidad de Valparaiso
José Luis Dinamarca, M.D.
Role: STUDY_CHAIR
Universidad de Valparaiso
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad de Valparaíso
Valparaíso, , Chile
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
study using the same ultrasonic device
The FRAX® algorithms give the 10-year probability of fracture.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1201311
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.